PB2392: MRNA IDENTIFICATION OF TIGIT IN PERITUMORAL LYMPHOCYTES IN CLASSICAL HODGKIN DISEASE

PB2392: MRNA IDENTIFICATION OF TIGIT IN PERITUMORAL LYMPHOCYTES IN CLASSICAL HODGKIN DISEASE

Bibliographic Details
Main Authors:	Ombretta Annibali, Valeria Tomarchio, Martina Verri, Maria Antonietta Tafuri, Antonella Bianchi, Anna Crescenzi, Luigi Rigacci
Format:	Article
Language:	English
Published:	Wiley 2023-08-01
Series:	HemaSphere
Online Access:	http://journals.lww.com/10.1097/01.HS9.0000976280.67526.78

Similar Items

2392
by: Ahsan Choudary, et al.
Published: (2017-09-01)

Stem Cells Collection and Mobilization in Adult Autologous/Allogeneic Transplantation: Critical Points and Future Challenges
by: Michele Prisciandaro, et al.
Published: (2024-03-01)

An antibiotic produced by Pseudomonas fluorescens CFBP2392 with antifungal activity against Rhizoctonia solani
by: Nadia Riera, et al.
Published: (2023-11-01)

Prognostic Implications of Intratumoral and Peritumoral Infiltrating Lymphocytes in Pancreatic Ductal Adenocarcinoma
by: Jung-Soo Pyo, et al.
Published: (2021-11-01)

Effects of ABVD chemotherapy on ovarian function: epidemiology, hormonal dosages and ultrasound morphologic analyses in 270 patients with Hodgkin’s disease
by: Mariavita Ciccarone, et al.
Published: (2023-04-01)

P018 (0139) GATA3 EXPRESSION DISTINGUISHES CLASSIC HODGKIN LYMPHOMA FROM NODULAR LYMPHOCYTE HODGKIN LYMPHOMA
Published: (2018-10-01)

TIGIT Expression on Intratumoral Lymphocytes Correlates with Improved Prognosis in Oral Squamous Cell Carcinoma
by: Jonas Eichberger, et al.
Published: (2022-12-01)

Genetics of classical Hodgkin Lymphoma
by: Gianluca Schiavoni, et al.
Published: (2018-06-01)

Prognostic Relevance of Nuclear Receptors in Relation to Peritumoral Inflammation and Tumor Infiltration by Lymphocytes in Breast Cancer
by: Melitta B. Köpke, et al.
Published: (2022-09-01)

Expression pattern of programmed death-1 in lymphocyte-rich classical Hodgkin lymphoma according to the growth patterns
by: Jai Hyang Go
Published: (2016-01-01)

Chronic lymphocytic leukemia/small lymphocytic lymphoma (CLL/SLL) with Reed-Sternberg-like cells with no convincing evidence of classic Hodgkin lymphoma
by: Latha K Abraham, et al.
Published: (2024-01-01)

Peritumoral edema at brain meningiomas
by: V. A. Byvaltsev, et al.
Published: (2016-02-01)

Controversies in the Treatment of Classical Hodgkin Lymphoma
by: Dennis A. Eichenauer, et al.
Published: (2018-10-01)

The Grey Zones of Classic Hodgkin Lymphoma
by: Jan Bosch-Schips, et al.
Published: (2022-01-01)

Classical Hodgkin’s Lymphoma Presenting as Erythroderma
by: Kumar Parimalam, et al.
Published: (2022-11-01)

Outcome of Children and Adolescents with Recurrent Classical Hodgkin Lymphoma: The Italian Experience
by: Alberto Garaventa, et al.
Published: (2022-03-01)

The FOXP1 transcription factor is expressed in the majority of follicular lymphomas but is rarely expressed in classical and lymphocyte predominant Hodgkin's lymphoma.
by: Brown, P, et al.
Published: (2005)

Classic Hodgkin Lymphoproliferative Diseases Clonally Unrelated to B-Chronic Lymphocytic Leukemia Successfully Treated with Bendamustine Plus Rituximab
by: Shinya Rai, et al.
Published: (2018-09-01)

Prognostic significance of lymphocyte-to-monocyte ratio in patients with classical Hodgkin lymphoma before and after receiving first-line chemotherapy
by: Heba F. Taha, et al.
Published: (2022-03-01)

CAR-T Cell Therapy for Classical Hodgkin Lymphoma
by: Mikalai Katsin, et al.
Published: (2023-12-01)

Current directions in the treatment of classical Hodgkin lymphoma
by: Frank G. Keller, et al.
Published: (2023-11-01)

Treatment Of Classical Hodgkin Lymphoma: The State Of The Art
by: Carmino Antonio de Souza, et al.
Published: (2023-10-01)

Bone marrow involvement by classic Hodgkin lymphoma
by: Mohammad Barouqa, et al.
Published: (2022-05-01)

Evolution of drug therapy for classical Hodgkin lymphoma
by: N. Y. Samaneva, et al.
Published: (2022-09-01)

Aberrant synaptophysin expression in classic Hodgkin lymphoma
by: Soyoung Im, et al.
Published: (2022-11-01)

T006 (0079) THE PERIPHERAL BLOOD NEUTROPHIL PD-L1 AND LYMPHOCYTE PD-1 AXIS IN CLASSICAL HODGKIN LYMPHOMA AT DIAGNOSIS
Published: (2018-10-01)

ImmunoPET imaging of TIGIT in the glioma microenvironment
by: Sarah R. Vincze, et al.
Published: (2024-03-01)

TIGIT in Lung Cancer: Potential Theranostic Implications
by: Carlo Pescia, et al.
Published: (2023-04-01)

The landscape of TIGIT target and clinical application in diseases
by: Shu Rui, et al.
Published: (2022-09-01)

Circulating TIGIT±PD1+TPH, TIGIT ± PD1+TFH cells are elevated and their predicting role in systemic lupus erythematosus
by: Qing Luo, et al.
Published: (2024-03-01)

Morphological differentiation of peritumoral brain zone microglia.
by: G Anahí Salas-Gallardo, et al.
Published: (2024-01-01)

Current Knowledge about the Peritumoral Microenvironment in Glioblastoma
by: Gianluca Trevisi, et al.
Published: (2023-11-01)

Optimization of the first line treatment in classical Hodgkin's lymphoma
by: Pauline Brice
Published: (2018-06-01)

Classic Hodgkin lymphoma-nodular sclerosis – case report
by: Mihaela Lebedenco, et al.
Published: (2023-06-01)

Cell-Free DNA for the Management of Classical Hodgkin Lymphoma
by: Vincent Camus, et al.
Published: (2021-03-01)

Therapeutic Updates for Relapsed and Refractory Classical Hodgkin Lymphoma
by: Timothy J Voorhees, et al.
Published: (2020-10-01)

Novel Approaches in Molecular Characterization of Classical Hodgkin Lymphoma
by: Diede A. G. van Bladel, et al.
Published: (2022-06-01)

The Role of Immune Checkpoint Inhibitors in Classical Hodgkin Lymphoma
by: Nicholas Meti, et al.
Published: (2018-06-01)

An updated portrait of monocyte-macrophages in classical Hodgkin lymphoma
by: Isacco Ferrarini, et al.
Published: (2023-02-01)

Hodgkin lymphoma lymphocyte depletion diffuse fibrosis variant
by: Alejandro Ruiz Méndez, et al.
Published: (2008-01-01)